Advertisement
Journal Home
Search for

Volume 9, Issue 2, Pages 64-71 (April 2004)


View previous. 7 of 12 View next.

Purifying genomic DNA from whole blood on automated, high-throughput, and moderate-throughput platforms

Rex BitnerCorresponding Author Informationemail address, Susan Koller, Jacqui Sankbeil, Mark Denhart, Hemanth Shenoi

Abstract 

We describe three new automated methods for purifying genomic DNA from whole blood. The MagneSil® Blood Genomic, Max Yield System uses MagneSil® paramagnetic particles (PMPs) in a 96-well format to purify the maximal amount of DNA from a 200-μL blood sample. In contrast, the MagneSil® ONE, Fixed Yield Blood Genomic System uses MagneSil® Fixed Yield PMPs to purify a normalized amount of DNA from 60 μL of blood in a 96-well format. These methods are implemented on the Beckman Coulter Biomek® FX automated workstation. The MagneSil® KF Genomic System uses MagneSil® PMPs to purify DNA from 1 to 15 samples of 200-μL blood using the moderate-throughput Thermo Electron KingFisher® mL instrument.

The MagneSil® Blood Genomic System typically yields>4 μg per 200 μL of whole blood, depending on the white blood cell content. The MagneSil® ONE System is best suited where there is a requirement for purification of a narrow concentration range of DNA. This system purifies 1 μg (±50%) of DNA from 60 μL of blood. The MagneSil® KF System purifies 2 to 6 μg of DNA from 200 μL of blood. DNA purified using all of these methods is suitable for PCR, STR, READIT® SNP genotype analysis, and multiplexed PCR analysis.

Corresponding Author InformationCorrespondence: Rex Bitner, Promega Corporation, 2800 Woods Hollow Road, Madison, WI 53711; Phone: +1.608.274.4330; Fax: +1.608.277.2601

PII: S1535-5535(03)00203-X

doi:10.1016/j.jala.2003.12.001


View previous. 7 of 12 View next.